Menu

Arcutis Biotherapeutics, Inc. ARQT

Full chart Compare
Set alert

Price alert · ARQT

All alert types
25.55 USD -1.45 (-5.37%)

At closeNov 6, 2026, 4:00 PM EST

25.55 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

25.31 Day range 27.09
19.50 52-week range 34.05
YTD
-12.02%
1 year
+1.79%

Revenue & Expenses

Revenue → Gross Profit: $339.38MGross Profit → Expenses: $339.38MRevenue → Cost of Revenue: $36.70MExpenses → Selling, General & Admin: $274.55MExpenses → Research & Development: $77.05MExpenses → Other Expenses: $2.74MExpenses → Income Tax: $1.17MNet Loss → Expenses: $16.14MGross Profit$339.38MNet Loss$16.14MCost of Revenue$36.70MExpenses$355.52MSelling, General & Admin$274.55MResearch & Development$77.05MOther Expenses$2.74MIncome Tax$1.17MRevenue$376.07M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ARQT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
376.07M196.54M59.61M3.69M0
339.38M177.41M54.62M2.93M0
-12.23M-128.40M-241.10M-301.63M-206.53M
-16.14M-140.04M-262.14M-311.46M-206.36M
-0.13-1.16-3.78-5.66-4.18
ARQT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
43.22M71.95M89.32M54.88M97.99M
432.97M348.89M341.37M449.27M408.15M
243.49M191.35M252.70M239.69M110.47M
114.22M109.77M205.92M202.54M77.56M
189.48M157.54M88.67M209.58M297.68M
ARQT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-5.63M-112.16M-247.06M-257.71M-174.63M
-30.25M28.82M180.23M-87.20M-75.95M
6.97M66.20M101.32M301.80M281.95M
-686.00K-143.00K-428.00K-333.00K-995.00K
-28.74M-17.37M34.45M-43.12M31.37M